Clinical and genetic characteristics of Korean patients with Gaucher disease

被引:40
作者
Jeong, Seon-Yong [1 ]
Park, Sang-Jin [2 ]
Kim, Hyon J. [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Med Genet, Suwon 443721, South Korea
[2] MG MED Inc, Seoul 153781, South Korea
关键词
Gaucher disease; Lysosomal storage disorder; GBA gene; Mutation; GLUCOCEREBROSIDASE-GENE; MUTANT ALLELES; MUTATIONS; IDENTIFICATION; PREVALENCE; PSEUDOGENE; COMPLEXITY; EVOLUTION; JEWISH;
D O I
10.1016/j.bcmd.2010.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gaucher disease (GD) is an autosomal recessive glycolipid lysosomal storage disease caused by a deficiency of the beta-glucocerebrosidase enzyme (GBA). Allelic heterogeneity in GD has been well described. To date, more than 270 different GBA mutations have been reported. In order to determine the GBA mutation spectrum in Korean GD patients, we performed GBA mutation analysis of Korean patients and identified 72 GBA mutant alleles from 36 unrelated patients (100% identification), including 60 single-nucleotide substitutions, 6 single-nucleotide deletions, 4 recombinants, 1 splicing error, and 1 complex allele. N370S, the most common GBA mutation, was not detected, and most of the Korean GBA mutations were previously known to be rare, with the exception of L444P (similar to 21%). Three mutations, P201H, F347L+L444P, and c.630delC, are novel. Examination of the GBA mutant alleles found in 6 ethnic groups revealed that the prevalences of GBA mutant alleles in Korean patients are very different from those seen in Jewish, non-Jewish Caucasian, and Italian patients, but similar to those seen in Japanese and Chinese patients. Our data may provide greater understanding of GBA allelic heterogeneity and an Asian perspective(1) on correlations between genotypes and phenotypes, which may help further the development of better management strategies for patients with GD. (C) 2010 Published by Elsevier Inc.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 28 条
[1]   GLUCOCEREBROSIDASE MUTATIONS IN GAUCHER DISEASE [J].
BEUTLER, E ;
DEMINA, A ;
GELBART, T .
MOLECULAR MEDICINE, 1994, 1 (01) :82-92
[2]   Hematologically important mutations: Gaucher disease [J].
Beutler, E ;
Gelbart, T .
BLOOD CELLS MOLECULES AND DISEASES, 1998, 24 (01) :2-8
[3]   THE ROLE OF NEUROGENETICS IN GAUCHER DISEASE [J].
BRADY, RO ;
BARTON, NW ;
GRABOWSKI, GA .
ARCHIVES OF NEUROLOGY, 1993, 50 (11) :1212-1224
[4]  
Chen M, 2008, ARCH PATHOL LAB MED, V132, P851, DOI 10.1043/1543-2165(2008)132[851:GDROTL]2.0.CO
[5]  
2
[6]   Gaucher disease among Chinese patients: Review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles [J].
Choy, Francis Y. M. ;
Zhang, Weimin ;
Shi, Hui-Ping ;
Zay, Agnes ;
Campbell, Tessa ;
Tang, Nelson ;
Ferreira, Patrick .
BLOOD CELLS MOLECULES AND DISEASES, 2007, 38 (03) :287-293
[7]   X-ray structure of human acid-β-glucosidase, the defective enzyme in Gaucher disease [J].
Dvir, H ;
Harel, M ;
McCarthy, AA ;
Toker, L ;
Silman, I ;
Futerman, AH ;
Sussman, JL .
EMBO REPORTS, 2003, 4 (07) :704-709
[8]   Clinical and molecular characteristics of Japanese Gaucher disease [J].
Eto, Y ;
Ida, H .
NEUROCHEMICAL RESEARCH, 1999, 24 (02) :207-211
[9]   Analysis of the Glucocerebrosidase Gene and Mutation Profile in 144 Italian Gaucher Patients [J].
Filocamo, Mirella ;
Mazzotti, Raffaella ;
Stroppiano, Marina ;
Seri, Marco ;
Giona, Fiorina ;
Parenti, Giancarlo ;
Regis, Stefano ;
Corsolini, Fabio ;
Zoboli, Stefania ;
Gatti, Rosanna .
HUMAN MUTATION, 2002, 20 (03) :234-235
[10]   Recent clinical progress in Gaucher disease [J].
Grabowski, GA .
CURRENT OPINION IN PEDIATRICS, 2005, 17 (04) :519-524